1상초청 등록
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
연구 개요
The purpose of this study is to collect long-term safety data in participants with cancers including acute myeloid leukemia, non-Hodgkin lymphoma, myelodysplastic syndrome, chronic lymphocytic leukemia (type of cancer of the blood and bone marrow in which the bone marrow makes a large number of abnormal blood cells) and advanced solid tumors and metastatic castration-resistant prostate cancer (mCRPC).
- 스폰서
- 리드: 얀센(J&J)
- 적응증
- Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neoplasms, Solid Tumor, Adult, Prostatic Neoplasms, Castration-Resistant
- 중재
- JNJ-75348780, JNJ-67856633, JNJ-54179060, JNJ-64264681, JNJ-74856665, JNJ-70218902, JNJ-64619178, JNJ-80948543, JNJ-87801493
- 목표 등록
- 120명
- 시작일
- 2024-12-30
- 완료(예정)
- 2028-10-30
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.